For many research teams, submitting to an ethics committee feels like sending a document into a black box and hoping for the best. In reality, reviewers are working through a fairly consistent set of questions — and understanding what they are gives you a much better chance of a smooth, fast review.
What reviewers are actually working through
Ethics committees don't operate arbitrarily. The review process follows a structured sequence of questions, each building on the last. Working through them in order before you submit is the most effective preparation you can do.
1. Is the science sound enough to justify involving people?
Before anything else, reviewers ask whether the study is likely to produce meaningful, usable results. A well-intentioned study that is too small, too poorly designed, or asking a question that has already been answered cannot ethically justify the time, data, or risk it asks of participants. Scientific quality is the foundation that everything else sits on.
- Is the research question clearly defined and not already answered?
- Is the sample size sufficient to draw meaningful conclusions?
- Is the methodology appropriate and proportionate?
2. Is the risk proportionate to the benefit?
Reviewers weigh what participants are being asked to do — their time, any procedures, the sensitivity of the data — against what the study could plausibly deliver, for participants, for the field, and for society. This isn't about eliminating risk; it's about making sure risk has been honestly identified, minimised where possible, and justified by what the research stands to achieve.
- Have all foreseeable risks been named and addressed?
- Is there a credible plan to minimise them?
- Does the potential benefit justify asking participants to accept them?
3. Will participants really understand what they're agreeing to?
Committees read consent materials closely, and not just for accuracy. They're asking whether a non-specialist could pick up the information sheet and genuinely understand what taking part involves — what will happen, what the risks and benefits are, how their data will be used, and how to withdraw. Dense, jargon-heavy documents are one of the most common reasons reviewers come back with questions.
- Is the information sheet written in plain, accessible language?
- Does it clearly explain all procedures, data uses, and withdrawal rights?
- Is the consent form consistent with the information sheet?
4. How will data be collected, stored, and protected?
Especially for studies involving health information or other sensitive data, reviewers want to see a clear, proportionate plan: what is collected, where it is stored, who can access it, how long it is kept, and what happens to it at the end of the study. Vague answers here ("data will be stored securely") tend to invite further questions.
- Which data fields are collected, and why is each one necessary?
- Where is data stored, and who controls access?
- What is the retention period, and how will data be disposed of?
5. Does the team have the right skills and structure to deliver this safely?
Finally, reviewers consider whether the people running the study are equipped to do so — not just scientifically, but in terms of training, oversight, and what happens if something goes wrong. A strong protocol delivered by an inexperienced or under-resourced team still carries risk.
- Does the team have relevant qualifications and experience?
- Is there clear oversight and a named point of responsibility?
- Is there a plan for managing adverse events or withdrawals?
Putting it together
None of this is designed to catch researchers out. A committee that understands your study, trusts your consent process, and can see that you've thought through the risks is a committee that can say yes quickly. The applications that move fastest are usually the ones where every document — protocol, information sheet, consent form, risk assessment — tells the same clear, consistent story.
